<i>In Vitro</i> Skin Retention of Crisaborole after Topical Application

• Asıl Yazarlar: Adriana Fantini (Yazar), Anna Demurtas (Yazar), Sara Nicoli (Yazar), Cristina Padula (Yazar), Silvia Pescina (Yazar), Patrizia Santi (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2020-05-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Crisaborole, a nonsteroidal phosphodiesterase 4 inhibitor, represents the first nonsteroidal medication approved for the treatment of atopic dermatitis in over a decade. In this work, crisaborole skin permeation and retention was studied <i>in vitro</i> from a 2% ointment using porcine s...